We provide you with 20 years of free, institutional-grade data for TLRY stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TLRY. Explore the full financial landscape of TLRY stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2025-07-29 | 0001731348 | TLRY | 10-K | Url |
| 2025-04-08 | 0001731348 | TLRY | 10-Q | Url |
| 2025-01-10 | 0001731348 | TLRY | 10-Q | Url |
| 2024-10-10 | 0001731348 | TLRY | 10-Q | Url |
| 2024-10-10 | 0001731348 | TLRY | 10-Q | Url |
| 2024-07-30 | 0001731348 | TLRY | 10-K | Url |
| 2024-04-09 | 0001731348 | TLRY | 10-Q | Url |
| 2024-01-09 | 0001731348 | TLRY | 10-Q | Url |
| 2023-10-04 | 0001731348 | TLRY | 10-Q | Url |
| 2023-07-26 | 0001731348 | TLRY | 10-K | Url |
| 2023-04-10 | 0001731348 | TLRY | 10-Q | Url |
| 2023-01-09 | 0001731348 | TLRY | 10-Q | Url |
| 2022-10-07 | 0001731348 | TLRY | 10-Q | Url |
| 2022-07-28 | 0001731348 | TLRY | 10-K | Url |
| 2022-04-06 | 0001731348 | TLRY | 10-Q | Url |
| 2022-01-10 | 0001731348 | TLRY | 10-Q | Url |
| 2021-10-07 | 0001731348 | TLRY | 10-Q | Url |
| 2021-07-28 | 0001731348 | TLRY | 10-K | Url |
| 2021-05-10 | 0001731348 | TLRY | 10-Q | Url |
| 2021-02-19 | 0001731348 | TLRY | 10-K | Url |
| 2020-11-09 | 0001731348 | TLRY | 10-Q | Url |
| 2020-08-10 | 0001731348 | TLRY | 10-Q | Url |
| 2020-05-11 | 0001731348 | TLRY | 10-Q | Url |
| 2020-03-02 | 0001731348 | TLRY | 10-K | Url |
| 2019-11-13 | 0001731348 | TLRY | 10-Q | Url |
| 2019-08-13 | 0001731348 | TLRY | 10-Q | Url |
| 2019-05-15 | 0001731348 | TLRY | 10-Q | Url |
| 2019-03-25 | 0001731348 | TLRY | 10-K | Url |
| 2018-11-14 | 0001731348 | TLRY | 10-Q | Url |
| 2018-08-29 | 0001731348 | TLRY | 10-Q | Url |
| 2018-06-20 | 0001731348 | TLRY | S-1 | Url |
Tilray, Inc(NASDAQ:TLRY) 
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, clinics, pharmacies, governments, and hospitals; and for researchers for commercial purposes, as well as compassionate access and clinical res...
Website: http://www.tilray.com
Founded: 2013
Full Time Employees: 1,646
Founder: Brendan Kennedy, Christian Groh, Michael Blue
CEO: Irwin D.Simon
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report about TLRY stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.